Endoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes

Diabetes

Volumn 51, Issue 2, 2002, Pages 356-365

  Alexander, Angela M ^a   Crawford, Megan ^a   Bertera, Suzanne ^a   Rudert, William A ^a   Takikawa, Osamu ^b   Robbins, Paul D ^c   Trucco, Massimo ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INDOLEAMINE 2,3 DIOXYGENASE; CONCANAVALIN A; INSULIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRAFT SURVIVAL; HLA SYSTEM; INSULIN RELEASE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SPLEEN CELL; T LYMPHOCYTE; TROPHOBLAST; ADENOVIRUS; ANIMAL; CELL DIVISION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE TRANSFER; GENETICS; IMMUNOLOGY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY; SECRETION; SPLEEN; TIME; TRANSPLANTATION;

ADENOVIRIDAE; ANIMALS; CELL DIVISION; CONCANAVALIN A; CULTURE MEDIA; DIABETES MELLITUS, TYPE 1; FEMALE; GENE TRANSFER TECHNIQUES; GRAFT SURVIVAL; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 0035995944     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2.356     Document Type: Article

References (42)

1. Type I diabetes mellitus: A chronic autoimmune disease
2. Insulin-dependent diabetes mellitus as an autoimmune disease
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
4. Therapeutic controversy: Prevention and treatment of diabetes in children
5. Islet transplantation for patients with type 1 diabetes
6. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
7. Targeting autoimmune diabetes with gene therapy
8. Inhibition of T cell proliferation by macrophage tryptophan catabolism
9. Tryptophan degradation in transplanted tumor cells undergoing rejection
10. The role of indoleamine 2,3-dioxygenase in the anti-tumor activity of human interferon-gamma in vivo
11. Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase
12. IFN-gamma-mediated antimicrobial response: Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracelular Chlamydia spp. or Toxoplasma growth
13. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells
14. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci
15. Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation
16. 2 into the reaction products
17. Antioxidant activites of some tryptophan metabolites: Possible implication for inflammatory disease
18. Prevention of allogeneic fetal rejection by tryptophan catabolism
19. Breeding of non-obese, diabetic strain of mice
20. A severe combined immunodeficiency mutation in the mouse
21. Mouse islet cell lysis mediated by interleukin-1-induced Fas
22. Method for the isolation of intact islets of Langerhans from the rat pancreas
23. A new method for isolation of murine islets with markedly improved yields
24. Anatomy of the islet of langerhans
25. The determination of tryptophan in plasma, liver and urine
26. Error in the determination of tryptophan by the method of Denkla and Dewey: A revised procedure
27. Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue
28. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NON-Thyla donors
29. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice
30. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require the recruitment of host B lymphocytes
31. Preventative and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: An observation in nonobese diabetic mice
32. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy
33. Viral vectors for gene therapy
34. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
35. New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors
36. Herpes simplex virus vectors and gene transfer to the nervous system
37. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival
38. Standardization of procedure for efficient ex vivo gene transfer into porcine pancreatic islets with cationic liposomes
39. Lentiviral and adenoviral gene transfer to intact human islets of Langerhans in vitro: A comparison of transfer efficiency, transgene expression and β cell function
40. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1β-induced β cell impairment and activation of islet cell apoptosis
41. Immunology type 1 diabetes: Intervention and prevention strategies
42. Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IkB repressor